Status:
UNKNOWN
A Registry for Patients With Systemic Mastocytosis in China
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Conditions:
Systemic Mastocytoses
Eligibility:
All Genders
Brief Summary
The Registry for Patients With Systemic Mastocytosis in China is a voluntary, observational database that will capture demographic, socioeconomic, and disease information with systemic mastocytosis. N...
Detailed Description
Systemic Mastocytosis (SM) is an extremely rare and heterogeneous spectrum of diseases characterized by the buildup of genetically altered mast cells in bone marrow sections and/or other extracutaneou...
Eligibility Criteria
Inclusion
- 1\. Any patient with a diagnosis of systemic mastocytosis according to World Health Organization (WHO) classification, including subtypes of SM, who is willing and able to provide written online informed consent.
Exclusion
- None
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06013683
Start Date
September 1 2023
End Date
August 31 2025
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Suzhou, Jiangsu, China, 215006